Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 31 December 2025

JFrog stock falls about 3% today as year-end tech dip hits software names

JFrog stock falls about 3% today as year-end tech dip hits software names

NEW YORK, December 31, 2025, 12:50 ET — Regular session JFrog Ltd (FROG.O) shares fell 3.2% to $63.35 by midday in New York, after opening at $65.24 and hitting an intraday low of $62.72. The stock was trading in a $62.72 to $65.53 range. The move came as U.S. equities drifted lower in holiday-thinned trading on the final session of 2025, with technology stocks among the heavier weights. “Describing 2025 as ‘resilient’ might be an understatement,” Adam Turnquist, chief technical strategist at LPL Financial, said. Reuters Benchmark ETFs tracking the S&P 500 and Nasdaq were both modestly lower, underscoring a
31 December 2025
··
Why Netflix stock is up today: Warner Bros. board seen sticking with Netflix deal

Why Netflix stock is up today: Warner Bros. board seen sticking with Netflix deal

NEW YORK, December 31, 2025, 12:42 ET — Regular session Netflix Inc shares were up 0.4% at $94.19 in midday trading on Wednesday, after moving between $93.21 and $94.19 earlier in the session. Volume topped 10 million shares. The stock’s direction has become closely tied to deal headlines as Netflix tries to pull off one of the biggest moves in its history: buying major studio and streaming assets from Warner Bros. Discovery. That matters now because the transaction would reshape Netflix’s scale in film and television production and put fresh pressure on regulators weighing another major step in media consolidation.
31 December 2025
··
Intel stock today edges higher after Nvidia’s $5 billion stake filing — what investors watch next

Intel stock today edges higher after Nvidia’s $5 billion stake filing — what investors watch next

NEW YORK, December 31, 2025, 12:43 ET — Regular session. Intel (INTC) shares were up about 0.2% at $37.39 in midday trade on Wednesday, after a regulatory filing confirmed Nvidia had completed a $5 billion purchase of Intel stock. The shares have traded between $37.12 and $38.01 so far in the session. The disclosure matters because Intel is still in a capital-heavy rebuild, trying to fund manufacturing expansion while defending its core PC and server chip franchises against increasingly tough competition. It also keeps the spotlight on a rare strategic tie-up between two long-time rivals. Equity investments of this size
31 December 2025
···
Oracle stock slips as OpenAI funding update and insider sale filing keep AI spend in focus

Oracle stock slips as OpenAI funding update and insider sale filing keep AI spend in focus

NEW YORK, December 31, 2025, 12:42 ET — Regular session Oracle Corp (ORCL) shares were down 0.3% at $196.60 in midday New York trading on Wednesday, after closing at $197.21 in the prior session. The stock traded between $195.08 and $197.49 so far in the regular session. The weakness matched a modest pullback in U.S. technology shares, with the Nasdaq 100-tracking Invesco QQQ and the Technology Select Sector SPDR both down about 0.3%. The drift matters because Oracle’s valuation has been tied closely to investor confidence in AI-driven cloud growth and the cost of building out data-center capacity. Scrutiny rose
31 December 2025
··
Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul

Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul

NEW YORK, December 31, 2025, 12:30 ET — Regular session. Ondas Holdings Inc shares rose 11.9% to $10.06 by 12:30 p.m. ET on Wednesday, after earlier touching $10.32. The company said it received about $10 million in new purchase orders for its autonomous systems portfolio, including counter-UAS systems — technology designed to detect and disable hostile drones — along with autonomous drone and robotic ground platforms. “These new orders underscore the sustained, global demand we are seeing for autonomous air and ground systems,” Chairman and CEO Eric Brock said. Ondas Holdings The order update gives investors a fresh data point
31 December 2025
·
Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

NEW YORK, December 31, 2025, 11:55 ET — Regular session Shares of Cogent Biosciences slid on Wednesday, paring losses from earlier in the session, after the biotech disclosed a key regulatory filing while investors digested a cluster of insider stock sales. The stock was down 2.5% at $36.19, after touching a low of $34.33. The move comes as Cogent shifts from late-stage data to the U.S. Food and Drug Administration review process — a step that can widen the audience beyond biotech specialists and pull more short-term traders into the name. A New Drug Application, or NDA, is the formal
31 December 2025
··
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

NEW YORK, Dec 31, 2025, 12:20 ET — Regular session. AAON shares were down 2.7% at $76.48 in midday trade on Wednesday, after touching $79.67 earlier in the session. The move came two days after AAON disclosed it increased borrowing capacity on its existing credit facility to $600 million by exercising a previously available $100 million “accordion” feature — an option that lets borrowers expand a credit line under agreed terms. SEC Why it matters now: credit capacity tends to draw scrutiny when rates are still elevated and investors are quick to punish any sign that cash needs are rising
31 December 2025
·
Nike stock jumps on CEO buy as year-end traders watch the turnaround

Nike stock jumps on CEO buy as year-end traders watch the turnaround

NEW YORK, December 31, 2025, 12:20 ET — Regular session Nike (NKE) shares rose 4.1% to $63.72 in midday trading on Wednesday after a regulatory filing showed CEO Elliott Hill bought about $1 million of stock. The Form 4 filing, which discloses insider transactions, said Hill bought 16,388 Nike Class B shares on Dec. 29 at an average $61.10, lifting his direct holding to 241,587 shares. SEC Investors have been looking for signs that Nike’s turnaround is gaining traction after margin pressure and a slide in demand in parts of the business. Insider purchases can matter because they put executives’
31 December 2025
·
BKV stock slides as natural gas tumbles again — what traders are watching next

BKV stock slides as natural gas tumbles again — what traders are watching next

NEW YORK, December 31, 2025, 12:25 PM ET — Regular session BKV Corp shares slipped on Wednesday as the latest leg lower in U.S. natural gas prices weighed on sentiment across gas-linked producers. The stock was down about 2.6% at around $27.10 in midday trading, after touching $27.00. Why it matters now: natural gas has been driving the near-term tape for U.S. gas-heavy names, and the commodity moved sharply again into year-end. Henry Hub futures were last indicated down roughly 4.5% on the day, according to CME pricing. CME Group That kind of swing can quickly reset expectations for cash
31 December 2025
···
GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

NEW YORK, December 31, 2025, 12:13 ET — Regular session Alphabet’s Class C shares (GOOG) edged down 0.04% to $314.43 in midday trading on Wednesday, after an insider-trading filing showed the company’s chief legal officer sold shares. The stock has traded between $312.34 and $315.37 so far in the session. The move comes in thin year-end trading, when lower volumes can exaggerate short-term swings. Alphabet’s stock has been a heavyweight driver of U.S. equity gains in 2025, leaving investors alert to any sign of profit-taking as the calendar turns. Wall Street’s major indexes were slightly lower on the final trading
31 December 2025
··
Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

NEW YORK, December 31, 2025, 12:18 ET — Regular session Palantir Technologies Inc shares were down 0.4% at $180.18 in midday trading on Wednesday, easing alongside a muted pullback in U.S. equities on the final trading day of 2025. The stock has traded between $179.34 and $181.80, with volume around 8.8 million shares. Palantir has been one of 2025’s standout AI-linked software stocks, up about 140% for the year. Wedbush Securities analyst Dan Ives, who named Palantir a top AI stock pick for 2026, set a $230 price target and said demand for the company’s AI platform remained “unprecedented.” Business
31 December 2025
····
LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

NEW YORK, Dec 31, 2025, 12:13 ET — Regular session LandBridge Company LLC shares slid on Wednesday and briefly set a new 52-week low, extending a late-year pullback as investors weighed a weaker crude backdrop and a risk-off tone in energy-linked pockets of the market. Investing.com The stock was down 3.2% at $48.63 in midday trading, after touching an intraday low of $48.29 — below the prior 52-week floor flagged in market reports. Investing.com+1 The move matters now because LandBridge’s business is tied to activity in the Permian Basin through surface and related revenue streams, leaving sentiment sensitive to the
31 December 2025
·
Amazon stock slips in year-end trade as Evercore flags AMZN for 2026—what’s next

Amazon stock slips in year-end trade as Evercore flags AMZN for 2026—what’s next

NEW YORK, December 31, 2025, 12:10 ET — Regular session Amazon.com, Inc. shares dipped on Wednesday, down about 0.5% at $231.44 in midday trading. The muted move matters now because year-end trading typically brings lighter liquidity, making single-stock moves more sensitive to positioning than to fresh fundamentals. The broader tape stayed cautious on the final U.S. trading day of 2025, with major indexes edging lower in holiday-thinned volumes and U.S. markets set to close on Thursday for New Year’s Day. Reuters On the catalyst front, Evercore ISI analyst Mark Mahaney called Amazon his “top pick” for 2026 in a client
31 December 2025
··
Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

NEW YORK, December 31, 2025, 11:38 ET — Regular session Shares of Xometry Inc fell about 3.5% to $60.94 in midday trading on Wednesday, after closing at $63.14 in the prior session. The Nasdaq-listed stock traded as high as $63.94 and as low as $60.58. The drop outpaced a modest retreat in U.S. equities on the final trading day of 2025, with broad indexes edging lower in thin holiday liquidity ahead of markets’ New Year’s Day closure. Reuters Year-end repositioning has been a focus for investors as 2026 approaches. “It’s just a healthy rebalancing of allocations,” Mark Hackett, chief market
31 December 2025
···
MIAX slides as year-end trading thins — what traders are watching next

MIAX slides as year-end trading thins — what traders are watching next

NEW YORK, December 31, 2025, 12:19 ET — Regular session. Miami International Holdings, Inc. shares were down 2.2% on Wednesday midday, a softer tape in thin, year-end trading for the exchange operator. The stock last traded at $44.70, down $0.99 from the previous close, after moving between $44.05 and $46.00 in the session. (https://www.marketwatch.com/investing/stock/miax) MarketWatch Why it matters now: MIAX has become a closely watched “picks-and-shovels” bet on derivatives activity — and into the final sessions of the year, investors often focus less on new headlines and more on positioning, liquidity and supply-demand shifts in recently listed names. Reuters There
31 December 2025
·
Apple stock slips in year-end trading as tech drags; what investors watch next

Apple stock slips in year-end trading as tech drags; what investors watch next

NEW YORK, December 31, 2025, 12:07 ET — Regular session Apple shares dipped on Wednesday as investors continued to trim exposure to large technology names into the end of the year. The iPhone maker’s stock was down 0.2% at $272.63, after trading between $271.78 and $273.58. The move mattered because Apple’s enormous weighting in major indexes often makes it a bellwether for shifts in risk appetite on quiet days, when small flows can move prices more than usual. U.S. stocks were modestly lower in holiday-thin trading, extending a late-December drift that has undercut expectations for a “Santa Claus rally,” a
31 December 2025
·····
Broadcom stock slips today as insider sale filings hit tape in thin year-end trade

Broadcom stock slips today as insider sale filings hit tape in thin year-end trade

NEW YORK, December 31, 2025, 12:12 ET — Regular session Broadcom Inc. shares slipped in midday trading on Wednesday, down 0.7% at $347.36. The stock touched a session low of $345.43 as the final U.S. trading session of 2025 stayed choppy. The pullback matters because the semiconductor group is heading into 2026 with investors split on how much AI-driven spending can keep offsetting margin pressure from custom chips. Broadcom is a bellwether for that trade because it sells both AI-related silicon and enterprise software through VMware. Year-end trading can magnify small moves, and insider transactions draw extra attention in thin
31 December 2025
·
Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

NEW YORK, December 31, 2025, 11:51 ET — Regular session Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session. The move came without any new company announcements. Regencell’s investor-relations site lists its most recent press release dated Oct. 31, and the latest SEC filing on EDGAR is its annual report filed the same day. Regencell Bioscience -+1 The pullback also tracked a softer tape across Wall Street on the final trading day of 2025, with trading volumes muted heading into the New Year’s holiday.
31 December 2025
·
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

NEW YORK, December 31, 2025, 11:38 ET — Regular session Genmab A/S (GMAB) shares slid on Wednesday, down about 3.3% at $30.44 in New York trading, as investors weighed a late-stage pipeline cut and the closing steps of a major acquisition. The Nasdaq-listed ADR touched $30.36 after opening at $31.42. Genmab said on Dec. 29 it will discontinue further clinical development of acasunlimab following a portfolio review and said the move does not change its full-year 2025 financial guidance. “Although the data have been encouraging, the compelling opportunities we see in our late‑stage pipeline led us to focus our investments,”
31 December 2025
···
Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

NEW YORK, December 31, 2025, 11:55 ET — Regular session Tesla shares were down about 0.2% at $453.58 in late morning trading on Wednesday, extending a muted move as investors focused on near-term demand signals into year-end. The stock traded between $452.42 and $458.39 in the session. The market’s attention is on Tesla’s fourth-quarter and full-year production and delivery report due Friday, a closely watched update that investors use as an early read on demand before earnings. Analysts polled by Visible Alpha expect Tesla deliveries of about 432,810 vehicles for the quarter, down roughly 13% from a year earlier after
31 December 2025
···
1 … 544 545 546 547 548 … 1,171

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop